Lipids are insoluble in water and therefore cholesterol and triglycerides need to be
transported in association with proteins (ie, lipoproteins) in the bloodstream. Lipoproteins …

Lipid disorders involving derangements in serum cholesterol, triglycerides, or both are
commonly encountered in clinical practice and often have implications for cardiovascular …

Dyslipidemia is a fundamental risk factor for cardiovascular diseases (CVDs) and can
worsen the prognosis, if unaddressed. Lipid guidelines are still evolving as dyslipidemia is …

Novel pyrrolo [2, 3-b] pyrrole derivatives were synthesized and their hypolipidemic activity
was assessed in hyperlipidemic rats. The chemical structures of the new derivatives were …

During the past several decades, the major focus on lipids has been on low-density
lipoproteins (LDL), largely as a result of LDL-lowering therapeutic advances that have led to …

Background Assessing the spectrum of disease risk associated with hypertriglyceridemia is
needed to inform potential benefits from emerging triglyceride lowering treatments. We …

Hyperlipidemia is a major cause of atherosclerosis. Reverse cholesterol transport (RCT) is
believed to attenuate hyperlipidemia and the progression of atherosclerosis. Although …

Accumulating evidence has suggested that medium-, long-, and medium-chain (MLM)
structured lipids have anti-obesity effects, but whether they can alleviate the development of …

Background and aims Familial combined hyperlipidemia (FCHL) is one of the most common
inherited lipid phenotypes, characterized by elevated plasma concentrations of …

Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver
disease worldwide, with an estimated global prevalence of 32.4%. 1 Although a Division of …